ALT NASDAQ
Altimmune, Inc.
1W: -10.5%
1M: -16.5%
3M: -11.0%
YTD: -41.6%
1Y: -20.4%
3Y: +6.2%
5Y: -76.3%
$2.73
-0.03 (-0.91%)
Weekly Expected Move ±6.4%
$2
$3
$3
$3
$3
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+55.0% YoY
$-92M
Net Income
-4.6% YoY
$-77M
Free Cash Flow
+6.5% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-28.9%
ROA-25.6%
ROIC-43.1%
Valuation
P/E-3.5
P/B1.1
EV/EBITDA-2.9
Leverage
Debt/Equity0.08
Current Ratio26.78
Interest Cov.-26.2x
Quality Scores
Piotroski F4/9
Altman Z4.69
Beneish M0.00